Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,126.00    -32.00 (-1.48%)
Bid:
2,130.00
Ask:
2,136.00
Spread: 6.00 (0.282%)
Market Cap: £1.41b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

14 Sep 2022 16:41

RNS Number : 4954Z
Genus PLC
14 September 2022
 

14 September 2022

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 14 September 2022, conditional nil-cost share options were granted under the Genus 2019 Performance Share Plan ('PSP') over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ended 30 June 2022, nil-cost share options were granted over ordinary shares under the Genus 2019 Deferred Share Bonus Plan ('DSBP') as listed in table B below.

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2022 Annual Report.

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the nil-cost option awards made on 14 September 2022.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

Table A - GELT 2019 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Alison Henriksen

3. Bill Christianson

4. Nate Zwald

5. Jerry Thompson

6. Elena Rice

7. Angelle Rosata

8. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer

7. Group Human Resources Director

8. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the PSP over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 0p

43,504

2. 0p

29,492

3. 0p

23,396

4. 0p

19,906

5. 0p

19,906

6. 0p

20,294

7. 0p

18,334

8. 0p

17,678

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2022-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

Table B - GELT 2019 Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Alison Henriksen

3. Bill Christianson

4. Nate Zwald

5. Jerry Thompson

6. Elena Rice

7. Angelle Rosata

8. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer

7. Group Human Resources Director

8. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the DSBP following the compulsory deferral of 33% and 25% of annual bonus for Executive Directors and members of GELT respectively in respect of bonuses earned in the financial year ended 30 June 2022.

 

c.

Price(s) and volume(s)

Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 0p

2,257

2. 0p

2,257

3. 0p

401

4. 0p

547

5. 0p

1,111

6. 0p

231

7. 0p

419

8. 0p

404

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

e.

Date of the transaction

2022-09-14

 

f.

Place of the transaction

Outside a trading venue.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSOVRUKUKAAR
Date   Source Headline
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return
8th Jul 20143:34 pmRNSHolding(s) in Company
7th Jul 20148:42 amRNSHolding(s) in Company
4th Jul 20141:43 pmRNSHolding(s) in Company
2nd Jul 20145:03 pmRNSHolding(s) in Company
1st Jul 201410:00 amRNSTotal Voting Rights
9th Jun 20142:00 pmRNSCompany Secretary Change
27th May 20147:00 amRNSUpdate on Shennong Joint Venture in China
15th May 20147:00 amRNSInterim Management Statement
15th May 20147:00 amRNSStrategic Beef Partnership with ABP Food Group
3rd Apr 20144:29 pmRNSDirector/PDMR Shareholding
28th Mar 20142:22 pmRNSDirector/PDMR Shareholding
19th Mar 20144:05 pmRNSBoard Appointments
17th Mar 20144:35 pmRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSInterim Results
10th Feb 20147:00 amRNSCompletion of Acquisition of Genetiporc do Brasil
31st Jan 20142:00 pmRNSTotal Voting Rights
31st Jan 20142:00 pmRNSBlocklisting Interim Review
31st Dec 201312:41 pmRNSTotal Voting Rights
31st Dec 201312:41 pmRNSDirector/PDMR Shareholding
12th Dec 20133:00 pmRNSDirector/PDMR Shareholding
29th Nov 20135:01 pmRNSTotal Voting Rights
15th Nov 20133:02 pmRNSResult of AGM
15th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20134:25 pmRNSTotal Voting Rights
29th Oct 20132:30 pmRNSHolding(s) in Company
18th Oct 20137:00 amRNSCompletion of Acquisition of Génétiporc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.